Catalyst Event
Gilead Sciences Inc (GILD) · Other
From Akros U.S. Large Cap 500 Protective Allocation Monthly Index (A500PAM)
6/8/2026, 12:00:00 AM
Positive topline results from two Phase 3 studies (ISLEND-1 and ISLEND-2) for the investigational once-weekly oral HIV treatment, islatravir/lenacapavir, in partnership with Merck, on June 8, 2026. Medium impact estimated as this validates a key pipeline asset; expected.
Korean Translation
2026년 6월 8일, 머크(Merck)와 공동으로 개발 중인 주 1회 경구용 HIV 치료제 이슬라트라비르/레나카파비르에 대한 3상 임상 연구 2건(ISLEND-1 및 ISLEND-2)의 긍정적인 탑라인 결과 발표가 예상됨. 핵심 파이프라인 가치 입증에 따른 중간 정도의 영향이 예상됨.
Related Recent Events
Kinder Morgan Inc. (KMI) · Other
James Holland, Chief Operating Officer, is set to retire, effective September 4, 2026. Ken Grubb, currently VP and Chief Project Officer, will succeed him as COO. The transition was announced on April 22, 2026. Impact is estimated at 1% due to the planned nature of the succession scheduled.
9/4/2026, 12:00:00 AM
HEICO Corp (HEI) · Earnings Release
Q3 2026 earnings release on 2026-08-24 scheduled.
8/24/2026, 12:00:00 AM
Walmart Inc (WMT) · Earnings Release
Q2 FY2027 earnings release scheduled; medium impact from financial updates expected.
8/20/2026, 12:00:00 AM
Target Corp (TGT) · Earnings Release
Q2 2026 earnings release on August 19, 2026, with analysts forecasting an EPS of approximately $2.21-$2.25; low impact estimated as the market typically prices in consensus expectations prior to the release expected.
8/19/2026, 12:00:00 AM
CoreWeave Inc (CRWV) · Earnings Release
Q2 2026 earnings release for August 18, 2026, is of high importance as such releases often cause >10% price impact; event scheduled.
8/18/2026, 12:00:00 AM
Home Depot Inc. (The) (HD) · Earnings Release
Q2 2026 earnings release and conference call on August 18, 2026. Estimated price impact ~5% as earnings releases typically drive significant volatility; scheduled.
8/18/2026, 12:00:00 AM